Effective April 2, 2025, all screeners previously provided by Sivadata Pty Ltd have been transferred to Kalkine Pty Ltd, a related entity of Sivadata Pty Ltd. You can access these screeners via the link https://kalkine.com.au/screeners.
PRNews

Paranovus Entertainment Technology Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq

Cision | Wed, Jul 16 2025 06:15 AM AEST

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

NEW YORK, July 16, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited ("PAVS" or the "Company"), (NASDAQ: PAVS) announced today that on July 11, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq"), notifying the Company that the minimum bid price per share for its Class A ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).

The notification received has no immediate effect on the listing of the Company's Class A ordinary shares on Nasdaq. Under the Nasdaq Listing Rules, the Company has until January 7, 2026 to regain compliance. If at any time during such 180-day period the closing bid price of the Company's Class A ordinary shares is at least $1 for a minimum of 10 consecutive business days, Nasdaq will provide the Company written confirmation of compliance.

If the Company does not regain compliance during such 180-day period, the Company may be eligible for an additional 180 calendar days, provided that the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq except for Nasdaq Listing Rule 5550(a)(2), and provide a written notice of its intention to cure this deficiency during the second compliance period, by effecting a reverse stock split, if necessary. 

About Paranovus Entertainment Technology Limited

Paranovus Entertainment Technology Ltd. focuses on the development of AI-powered entertainment products, including AI-driven games and applications, as well as TikTok-related e-commerce solutions through its subsidiary. The Company is committed to delivering immersive and engaging experiences through innovative AI and digital commerce platforms.

In March 2025, the Company completed the acquisition of the controlling equity interests of Bomie Wookoo Inc., a New York company that offers e-commerce solutions. As part of its strategic transformation, Paranovus has exited its legacy businesses, including the e-commerce, internet information, and advertising businesses in September 2023 and ceased its automobile sales business in July 2024.

For more information on our latest innovations and developments, visit https://www.pavs.ai/.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following:  the Company's goals and strategies; the Company's future business development; the Company's future acquisition opportunities; the Company's ability to identify any acquisition opportunities that fit with our business strategies; the Company's ability to consummate an attractive acquisition and realize the benefits of such transaction; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic, the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

 

 

Market Updates

Asia Pacific’s Demand for IT and Business Services Slows in Q2, ISG Index™ Shows

Despite 16% growth in cloud ACV, the combined market was down slightly on slumping managed services demandSYDNEY--(BUSINESS WIRE)--$III #...

Business Wire | Wed, Jul 16 2025 01:00 PM AEST

Read More
PRNews

The Shift to Smarter Systems: Why Philippine Enterprises Choose HashMicro ERP

MANILA, Philippines, July 16, 2025 /PRNewswire/ -- The Philippines' IT landscape is evolving rapidly, with the ERP market projected to reach ...

Cision | Wed, Jul 16 2025 12:41 PM AEST

Read More
PRNews

Forrester's 2026 Budget Planning Guides: Leaders Grow More Cautious As Economic Uncertainty Persists

While volatility is here to stay, embracing scenario planning can help regain control SINGAPORE, July 16, 2025 /PRNewswire/ -- According to Forrester's&...

Cision | Wed, Jul 16 2025 12:37 PM AEST

Read More
PRNews

Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors

TAIPEI and SAN DIEGO, July 16, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics ...

Cision | Wed, Jul 16 2025 12:32 PM AEST

Read More
Market Updates

Newmont Announces Monetization of Equity Received Through Successful Divestiture Program

Expected to Generate ~$470 million in Net Proceeds, Reflecting Strong Equity Appreciation Newmont Remains on Track to Deliver on its 2025 Guidance ...

Business Wire | Wed, Jul 16 2025 12:30 PM AEST

Read More